T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$1.86B |
| 2 |
VMW
VMware, Inc
VMW
|
+$1.49B |
| 3 |
Broadcom
AVGO
|
+$1.29B |
| 4 |
Sempra
SRE
|
+$1.26B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PayPal
PYPL
|
+$1.66B |
| 2 |
HCA Healthcare
HCA
|
+$1.02B |
| 3 |
BNY
Bank of New York Mellon
BNY
|
+$949M |
| 4 |
American Tower
AMT
|
+$931M |
| 5 |
FRC
First Republic Bank
FRC
|
+$890M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.07% |
| 2 | Financials | 16.19% |
| 3 | Technology | 16.15% |
| 4 | Consumer Discretionary | 13.93% |
| 5 | Industrials | 9.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Agios Pharmaceuticals
AGIO
$2B
| $104M | 0.02% |
1,824,846
+77,710
| +4% | +$4.89M |
|
627
Sarepta Therapeutics
SRPT
$1.95B
| $104M | 0.02% |
1,870,076
+1,087,295
| +139% | +$57.6M |
|
628
Monster Beverage
MNST
$91.4B
| $104M | 0.02% |
6,568,908
-258,904
| -4% | -$3.88M |
|
|
PE
629
DELISTED
PARSLEY ENERGY INC
PE
| $103M | 0.02% |
3,508,804
-1,677,006
| -32% | -$44.8M |
|
630
Liberty Broadband Class C
LBRDK
$5.29B
| $103M | 0.02% |
1,208,767
-110,773
| -8% | -$9.86M |
|
631
Steel Dynamics
STLD
$37.3B
| $103M | 0.02% |
2,379,712
+2,163,939
| +1,003% | +$83.2M |
|
632
Okta
OKTA
$26.9B
| $103M | 0.02% |
4,004,071
+2,621,552
| +190% | +$73.3M |
|
|
AJRD
633
DELISTED
Aerojet Rocketdyne Holdings
AJRD
| $102M | 0.02% |
3,280,543
+673,670
| +26% | +$21.3M |
|
634
Tenaris
TS
$26.6B
| $102M | 0.02% |
3,198,432
+18,232
| +0.6% | +$528K |
|
635
Jack in the Box
JACK
$358M
| $101M | 0.02% |
1,032,675
-1,413,409
| -58% | -$144M |
|
636
Rockwell Automation
ROK
$49.5B
| $101M | 0.02% |
515,937
+292,356
| +131% | +$55.7M |
|
637
National Bank Holdings
NBHC
$1.94B
| $101M | 0.02% |
3,119,024
-120,210
| -4% | -$4M |
|
|
PRA
638
DELISTED
ProAssurance
PRA
| $101M | 0.02% |
1,761,281
-58,962
| -3% | -$3.44M |
|
639
A.O. Smith
AOS
$8.49B
| $101M | 0.02% |
1,640,116
+1,246,693
| +317% | +$75.7M |
|
640
Vistra
VST
$49.1B
| $100M | 0.02% |
5,478,117
+1,524,875
| +39% | +$28.6M |
|
641
Matsons
MATX
$6.39B
| $99.8M | 0.02% |
3,344,145
+436
| +0% | +$12.3K |
|
642
Steven Madden
SHOO
$3.46B
| $99.5M | 0.02% |
3,194,634
+36,877
| +1% | +$1.03M |
|
643
Lantheus
LNTH
$6.59B
| $99M | 0.02% |
4,839,949
-545,766
| -10% | -$11.1M |
|
644
General Dynamics
GD
$106B
| $98.5M | 0.02% |
484,087
-12,903
| -3% | -$2.64M |
|
645
Avient
AVNT
$4.23B
| $98.5M | 0.02% |
2,263,664
+255,511
| +13% | +$11.2M |
|
646
Ultragenyx Pharmaceutical
RARE
$2.6B
| $98.4M | 0.02% |
2,120,855
+496,135
| +31% | +$24.3M |
|
|
NBIS
647
Nebius Group N.V.
NBIS
$69.3B
| $98.3M | 0.02% |
3,002,136
-14,010
| -0.5% | -$457K |
|
648
Ollie's Bargain Outlet
OLLI
$4.7B
| $97.9M | 0.02% |
1,837,572
-69,181
| -4% | -$3.26M |
|
649
AZZ Inc
AZZ
$4.52B
| $97.8M | 0.02% |
1,913,006
-38,023
| -2% | -$1.8M |
|
|
ALEX
650
DELISTED
Alexander & Baldwin
ALEX
| $97.8M | 0.02% |
3,523,890
+184,349
| +6% | +$7.19M |
|
Similar funds
T. Rowe Price Associates's Q4 2017 Portfolio in Review
As of Q4 2017, T. Rowe Price Associates held 2,692 positions worth $616B, up 5.3% from $585B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
T. Rowe Price Associates's Q4 2017 filing shows 121 new, 947 increased, 1,282 reduced and 130 closed positions. Its largest new stake was CarGurus: 13,060,603 shares worth $374M. The largest sale was PayPal, an estimated $1.66B.
By sector, the portfolio is most concentrated in Healthcare at 17% of assets, down from 18% a quarter earlier, followed by Financials and Technology.
- T. Rowe Price Associates's largest Q4 2017 buy was CarGurus: 13,060,603 shares worth $374M.
- T. Rowe Price Associates added most to Tesla in Q4 2017, an estimated $1.86B increase.
- T. Rowe Price Associates's biggest Q4 2017 reduction was PayPal, cutting an estimated $1.66B.
- T. Rowe Price Associates fully exited Kite Pharma, Inc. in Q4 2017, selling an estimated $483M.
- T. Rowe Price Associates's ten largest holdings make up 19% of its $616B portfolio in Q4 2017.
- T. Rowe Price Associates opened 121 new positions and closed 130 in Q4 2017.
- T. Rowe Price Associates's portfolio value rose 5.3% quarter-over-quarter to $616B.
Based on T. Rowe Price Associates's 13F filing for Q4 2017, filed 14 Feb 2018.